The Department of Surgery

Reagan W. Bollig, MD

Assistant Professor
Division of Trauma & Critical Care Surgery

Clinical Focus

General Surgery, Trauma, Surgical Critical Care, GI Surgery, Laparoscopic Surgery, Hernia Surgery, Robotic Surgery, Complex Abdominal Wall Reconstrution

Education

Medical School
University of South Alabama College of Medicine, Mobile, AL, 2007

Residency
General Surgery, Wake Forest University Baptist Medical Center, Winston-Salem, NC, 2012

Fellowship
Surgical Critical Care, University of Tennessee Graduate School of Medicine, Knoxville, TN, 2013

Certification

American Board of Surgery, General Surgery
American Board of Surgery, Surgical Critical Care

Professional Affiliations

American College of Surgeons
Society of Critical Care Medicine
Eastern Association for the Surgery of Trauma
Southeastern Surgical Congress
Association for Academic Surgery

Current Publications

Whitaker C, McKinney A, Bollig R, Hieb N, Roberts RF Jr, Rowe AS.
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients. J Thromb Thrombolysis. 2022 May;53(4):861-867. doi: 10.1007/s11239-021-02605-1. Epub 2021 Nov 17.

Whitaker C, McKinney A, Bollig R, Hieb N, Roberts RF Jr, Rowe AS.
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients. J Thromb Thrombolysis. 2022 May;53(4):861-867. doi: 10.1007/s11239-021-02605-1. Epub 2021 Nov 17.

Whitaker C, McKinney A, Bollig R, Hieb N, Roberts RF Jr, Rowe AS.
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients. Journal of Thrombosis and Thrombolysis. 2021 Nov 17. [Epub ahead of print]

Whitaker C, McKinney A, Bollig R, Hieb N, Roberts RF Jr, Rowe AS.
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients. Journal of Thrombosis and Thrombolysis. 2021 Nov 17. [Epub ahead of print]

Whitaker C, McKinney A, Bollig R, Hieb N, Roberts RF Jr, Rowe AS.
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients. Journal of Thrombosis and Thrombolysis. 2021 Nov 17. [Epub ahead of print]

Current Presentations

Mazonas T, Grant M, Scott S, Bollig R, and Daley B.. Management of isolated mild TBI at UTMCK: An opportunity for improvement Presented at Southeastern Surgical Congress; 2023 Feburary - 11; Savannah.